{"id":"irbesartan-atorvastatin-b","safety":{"commonSideEffects":[{"rate":null,"effect":"Dizziness"},{"rate":null,"effect":"Fatigue"},{"rate":null,"effect":"Muscle pain (myalgia)"},{"rate":null,"effect":"Elevated liver enzymes"},{"rate":null,"effect":"Hyperkalemia"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Irbesartan blocks the angiotensin II type 1 receptor, reducing vasoconstriction and aldosterone secretion to lower blood pressure. Atorvastatin inhibits HMG-CoA reductase, the rate-limiting enzyme in cholesterol synthesis, thereby reducing LDL cholesterol and cardiovascular risk. The combination addresses two major cardiovascular risk factors simultaneously.","oneSentence":"Irbesartan/Atorvastatin B is a fixed-dose combination that lowers blood pressure via angiotensin II receptor blockade and reduces cholesterol via HMG-CoA reductase inhibition.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:17:15.543Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Hypertension with dyslipidemia"},{"name":"Cardiovascular risk reduction in patients requiring both antihypertensive and lipid-lowering therapy"}]},"trialDetails":[{"nctId":"NCT01442987","phase":"PHASE3","title":"Efficacy and Safety of Irbesartan and Atorvastatin in Hypertension and Hyperlipidemia","status":"COMPLETED","sponsor":"Hanmi Pharmaceutical Company Limited","startDate":"2011-05","conditions":"Hypertension, Hyperlipidemia","enrollment":230}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["HCP0912 B"],"phase":"phase_3","status":"active","brandName":"Irbesartan/Atorvastatin B","genericName":"Irbesartan/Atorvastatin B","companyName":"Hanmi Pharmaceutical Company Limited","companyId":"hanmi-pharmaceutical-company-limited","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Irbesartan/Atorvastatin B is a fixed-dose combination that lowers blood pressure via angiotensin II receptor blockade and reduces cholesterol via HMG-CoA reductase inhibition. Used for Hypertension with dyslipidemia, Cardiovascular risk reduction in patients requiring both antihypertensive and lipid-lowering therapy.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}